This can hinder your business
growth and prevent your company from taking the next step in the evolution of entrepreneurship because,
without it, you have no
stable foundation from which to build on.
Thus, treatment with X4 - ZFNs of both wild - type and ccr5Δ32 CD4 + T cells confers
stable cxcr4 disruption and a marked survival advantage in the presence of R5X4 - HIV and X4 - HIV in vitro
without any detectable effect on cell
growth or viability in the absence of HIV.